Yamakado Koichiro Department
Specialty Division
Radiology, Clinical Medicine Seminars
Position
■ Journal
1.
Case report
11C-Choline positive but 18F-FDG negative pancreatic metastasis from renal cell carcinoma on PET 2017/02
2.
Original article
Choline PET/CT Imaging for Management of Prostate Cancer 2017/03
3.
Original article
11C-Choline positive but 18F-FDG negative pancreatic metastasis from renal cell carcinoma on PET 2017/05
4.
Case report
Diagnostic performance of (11)C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer. 2017/08
5.
Case report
Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by11C-Choline PET/CT. 2018/01
6.
Other
Tumor response to neoadjuvant chemotherapy in patients with esophageal cancer assessed with CT and FDG-PET/CT - RECIST 1.1 vs. PERCIST 1.0. 2018/04
7.
Other
Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0. 2018/05
8.
Other
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. 2018/06
9.
Original article
Comparison of 11C-choline Positron Emission Tomography/Computed Tomography (PET/CT) and Conventional Imaging for Detection of Recurrent Prostate Cancer. 2018/07
10.
Original article
The Potential Use of 11C-Choline Positron Emission Tomography/Computed Tomography to Monitor the Treatment Effects of Radium-223 in a Patient with Prostate Cancer. 2018/07
11.
Other
Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST. 2018/08
12.
Other
Diagnostic performance of 11C-choline PET/CT and FDG PET/CT for staging and restaging of renal cell cancer. 2018/08
13.
Original article
Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison 11C-choline and FDG PET/CT with dynamic contrast-enhanced CT 2018/10
14.
Original article
Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial chemoradiotherapy for maxillary sinus squamous cell carcinoma. 2018/11
15.
Original article
Usefulness of quantitative bone single photon emission computed tomography/computed tomography for evaluating response to neoadjuvant chemotherapy in a patient with periosteal osteosarcoma. 2018/11
16.
Original article
Diagnostic performance of 11C-choline PET/CT and FDG PET/CT for staging and restaging of renal cell cancer. 2018/12
17.
Original article
Early evaluation of tumor response to90 2019/07
18.
Original article
Evaluation of Treatment Response in Prostate Cancer and Renal Cell Carcinoma Patients Using 11C-choline PET/CT Findings. 2019/08
19.
Original article
Diffusion-weighted MRI, 11 C-choline PET/CT, and 18 F-FDG PET/CT for Predicting the Gleason Score in Prostate Cancer 2020/03
20.
Case report
Accurate Monitoring of the Response of Bone Metastases to Treatment in Patients with Prostate Cancer Using Choline PET/CT. 2021/01
21.
Original article
Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening. 2021/01
22.
Case report
CT Findings of Primary Renal Angiosarcoma. 2021/01
23.
Case report
Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT. 2021/01
24.
Case report
Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer. 2021/01
25.
Case report
Adrenal pheochromocytoma treated by combination of adrenal arterial embolization and radiofrequency ablation. 2021/03
26.
Original article
Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT. 2021/06
27.
Original article
CT and MRI Findings of Inflammatory Myofibroblastic Tumor in the Bladder 2022/01
28.
Original article
Evaluation of 11C-choline positron emission tomography/computed tomography for determining treatment response in castration-resistant prostate cancer patients. 2022/07
29.
Original article
Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma. 2022/09
30.
Original article
Differentiation of Angiomyolipoma With Minimal Fat from Clear Cell Renal Cell Carcinoma Using Non-contrast Multiparametric Magnetic Resonance Imaging. 2022/11
31.
Case report
Detection of Abdominal Lymph Node Metastasis from Pancreatic Neuroendocrine Tumor by Somatostatin Receptor Scintigraphy: Comparison with Somatostatin Receptor Type 2 Immunostaining 2023/01
32.
Original article
Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial. 2023/04
33.
Original article
Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial. 2023/05
Diagnostic performance of 11C*choline PET/CT and bone scintigraphy in the detection ob bone metastasisi in patients of prostate cancer (ポスター掲示,一般) 2017/10/22
2.
Renal Arterial Embolization for Renal Angiomyolipoma; what is the optimal method? (口頭,一般) 2019/02
3.
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT for Staging and Restaging of Renal Cell Carcinoma (ポスター掲示) 2020/12/22